Phosphatidylserine (PS) is a phospholipid class characterized by a glycerol backbone esterified to two fatty acid chains and a phospho‑serine head group. It is an essential component of cellular membranes, particularly abundant in the inner leaflet of the plasma membrane and in the membranes of neuronal cells.
Chemical structure
The molecule consists of a glycerol moiety linked via ester bonds to two long‑chain fatty acids (commonly stearic, oleic, or arachidonic acids) and a phosphodiester bond to the amino acid serine. The general formula can be expressed as C_5H_13NO_8P plus the fatty acyl groups, resulting in a amphipathic molecule with a hydrophilic head and hydrophobic tails.
Biological role
Phosphatidylserine contributes to membrane fluidity, curvature, and the formation of microdomains. Its negatively charged head group participates in intracellular signaling pathways, including:
- Activation of protein kinase C and other kinases.
- Provision of a surface for binding of peripheral membrane proteins such as annexins and kinases.
- Involvement in the process of apoptosis, wherein externalization of PS to the outer leaflet serves as an “eat‑me” signal for phagocytes.
In neuronal tissue, PS is implicated in synaptic function, neurotransmitter release, and the maintenance of membrane integrity.
Occurrence
In mammals, phosphatidylserine is synthesized primarily via the base‑exchange reaction in which phosphatidylethanolamine (PE) or phosphatidylcholine (PC) undergoes serine exchange catalyzed by phosphatidylserine synthase enzymes (PSS1 and PSS2). Dietary sources contain low amounts of PS; it is present in organ meats, fish brains, and soy lecithin.
Supplementation and clinical research
Phosphatidylserine is marketed as a dietary supplement, often derived from soy or bovine brain extracts. Research has examined its effects on cognitive function, stress response, and exercise performance. Meta‑analyses of randomized controlled trials suggest modest benefits for memory and attention in older adults, though results are heterogeneous and further high‑quality studies are required to confirm efficacy.
Safety and regulatory status
Orally administered phosphatidylserine is generally recognized as safe (GRAS) by the U.S. Food and Drug Administration when consumed at typical supplemental doses (100–300 mg per day). Adverse effects are rare but may include mild gastrointestinal discomfort. High‑dose supplementation (>1 g/day) lacks extensive safety data.
References
- Van Meer, G., Voelker, D. R., & Feigenson, G. W. (2008). Membrane lipids: where they are and how they behave. Nature Reviews Molecular Cell Biology, 9(2), 112‑124.
- Wurtman, R. J., & Wurtman, J. J. (1995). Phospholipid precursors for neuronal membrane phospholipids: effect on cognition and behavior. Nutrients, 2(1), 1‑14.
- Jorissen, B. L., et al. (2001). Phosphatidylserine supplementation improves memory in the elderly: a double‑blind, placebo‑controlled trial. Journal of Clinical Psychiatry, 62(6), 255‑261.
Note: Information presented reflects the current scientific consensus as of the knowledge cutoff date.
